"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist ...
WSYR Syracuse on MSN10h
CNY man is first patient in US to receive new prostate cancer treatment pre-chemotherapyOn March 28, the Food and Drug Administration approved Pluvicto, a new radiation agent able to treat patients with prostate cancer. Just six days later, James ...
Deutsche Bank analyst Emmanuel Papadakis raised the firm’s price target on Novartis (NVS) to CHF 115 from CHF 110 and keeps a Buy rating on the ...
In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on Novartis AG (NOVN – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback